Skip to main content
Top

05-05-2024 | Hepatocellular Carcinoma | Hepatobiliary

Preoperative prediction power of radiomics and non-radiomics methods based on MRI for early recurrence in hepatocellular carcinoma: a systemic review and meta-analysis

Authors: Mingjie Lu, Chen Wang, Yi Zhuo, Junjiu Gou, Yingfeng Li, Jingqi Li, Xue Dong

Published in: Abdominal Radiology

Login to get access

Abstract

Objective

To compare radiomics and non-radiomics in predicting early recurrence (ER) in patients with hepatocellular carcinoma (HCC) after curative surgery.

Methods

We systematically searched PubMed and Embase databases. Studies with clear reference criteria were selected. Data were extracted and assessed for quality using the quality in prognosis studies tool (QUIPS) by two independent authors. All included radiomics studies underwent radiomics quality score (RQS) assessment. We calculated sensitivity, specificity, positive likelihood ratio (PLR), and negative likelihood ratio (NLR) using random or fixed models with a 95%CI. Forest maps visualized the data, and summary receiver operating characteristic (sROC) curves with the area under the curve (AUC) were generated. Meta-regression and subgroup analyses explored sources of heterogeneity. We compared sensitivity, specificity, PLR, and NLR using the z-test and compared AUC values using the Delong test.

Results

Our meta-analysis included 10 studies comprising 1857 patients. For radiomics, the pooled sensitivity, specificity, AUC of sROC, PLR and NLR were 0.84(95%CI: 0.78–0.89), 0.80(95%CI: 0.75–0.85), 0.89(95%CI: 0.86–0.91), 4.28(95%CI: 3.48–5.27) and 0.20(95%CI: 0.14–0.27), respectively, but with significant heterogeneity (I2 = 60.78% for sensitivity, I2 = 55.79% for specificity) and potential publication bias (P = 0.04). The pooled sensitivity, specificity, AUC of sROC, PLR, NLR for non-radiomics were 0.75(95%CI:0.68–0.81), 0.78(95%CI:0.72–0.83), 0.83(95%CI: 0.80–0.86), 3.45(95%CI: 2.68–4.44) and 0.32(95%CI: 0.24–0.41), respectively. There was no significant heterogeneity in this group (I2 = 0% for sensitivity, I2 = 17.27% for specificity). Radiomics showed higher diagnostic accuracy (AUC: 0.89 vs. 0.83, P = 0.0456), higher sensitivity (0.84 vs. 0.75, P = 0.0385) and lower NLR (0.20 vs. 0.32, P = 0.0287).

Conclusion

The radiomics from preoperative MRI effectively predicts ER of HCC and has higher diagnostic accuracy than non-radiomics. Due to potential publication bias and suboptimal RQS scores in radiomics, these results should be interpreted cautiously.

Graphical abstract

Appendix
Available only for authorised users
Literature
1.
go back to reference 1 Sugawara Y, Hibi T (2021) Surgical treatment of hepatocellular carcinoma. Biosci Trends 15:138-141CrossRefPubMed 1 Sugawara Y, Hibi T (2021) Surgical treatment of hepatocellular carcinoma. Biosci Trends 15:138-141CrossRefPubMed
2.
go back to reference 2 Kumar AM, Fredman ET, Coppa C, El-Gazzaz G, Aucejo FN, Abdel-Wahab M (2015) Patterns of cancer recurrence in localized resected hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 14:269-275CrossRefPubMed 2 Kumar AM, Fredman ET, Coppa C, El-Gazzaz G, Aucejo FN, Abdel-Wahab M (2015) Patterns of cancer recurrence in localized resected hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 14:269-275CrossRefPubMed
3.
4.
go back to reference 4 Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723-750CrossRefPubMed 4 Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723-750CrossRefPubMed
6.
go back to reference 6 Vogel A, Cervantes A, Chau I et al (2018) Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv238-iv255CrossRefPubMed 6 Vogel A, Cervantes A, Chau I et al (2018) Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv238-iv255CrossRefPubMed
7.
go back to reference 7 Ren Y, Bo L, Shen B et al (2023) Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection. Med Phys 50:778-790CrossRefPubMed 7 Ren Y, Bo L, Shen B et al (2023) Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection. Med Phys 50:778-790CrossRefPubMed
8.
go back to reference 8 Lv K, Cao X, Du P, Fu JY, Geng DY, Zhang J (2022) Radiomics for the detection of microvascular invasion in hepatocellular carcinoma. World J Gastroenterol 28:2176-2183CrossRefPubMedPubMedCentral 8 Lv K, Cao X, Du P, Fu JY, Geng DY, Zhang J (2022) Radiomics for the detection of microvascular invasion in hepatocellular carcinoma. World J Gastroenterol 28:2176-2183CrossRefPubMedPubMedCentral
9.
go back to reference 9 Wu Q, Yu YX, Zhang T et al (2023) Preoperative Diagnosis of Dual-Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models. J Magn Reson Imaging 57:1185-1196CrossRefPubMed 9 Wu Q, Yu YX, Zhang T et al (2023) Preoperative Diagnosis of Dual-Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models. J Magn Reson Imaging 57:1185-1196CrossRefPubMed
10.
go back to reference 10 Xia TY, Zhou ZH, Meng XP et al (2023) Predicting Microvascular Invasion in Hepatocellular Carcinoma Using CT-based Radiomics Model. Radiology 307:e222729CrossRefPubMed 10 Xia TY, Zhou ZH, Meng XP et al (2023) Predicting Microvascular Invasion in Hepatocellular Carcinoma Using CT-based Radiomics Model. Radiology 307:e222729CrossRefPubMed
11.
go back to reference 11 Zhao JW, Shu X, Chen XX et al (2022) Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram. Hepatobiliary Pancreat Dis Int 21:543-550CrossRefPubMed 11 Zhao JW, Shu X, Chen XX et al (2022) Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram. Hepatobiliary Pancreat Dis Int 21:543-550CrossRefPubMed
12.
go back to reference 12 Li XQ, Wang X, Zhao DW et al (2020) Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma. World J Surg Oncol 18:219CrossRefPubMedPubMedCentral 12 Li XQ, Wang X, Zhao DW et al (2020) Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma. World J Surg Oncol 18:219CrossRefPubMedPubMedCentral
13.
go back to reference 13 Bell M, Turkbey EB, Escorcia FE (2020) Radiomics, Radiogenomics, and Next-Generation Molecular Imaging to Augment Diagnosis of Hepatocellular Carcinoma. Cancer J 26:108-115CrossRefPubMed 13 Bell M, Turkbey EB, Escorcia FE (2020) Radiomics, Radiogenomics, and Next-Generation Molecular Imaging to Augment Diagnosis of Hepatocellular Carcinoma. Cancer J 26:108-115CrossRefPubMed
14.
go back to reference 14 Li W, Shen H, Han L et al (2022) A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma. J Oncol 2022:3704987CrossRefPubMedPubMedCentral 14 Li W, Shen H, Han L et al (2022) A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma. J Oncol 2022:3704987CrossRefPubMedPubMedCentral
15.
go back to reference 15 Kermany DS, Goldbaum M, Cai W et al (2018) Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning. Cell 172:1122-1131.e1129CrossRefPubMed 15 Kermany DS, Goldbaum M, Cai W et al (2018) Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning. Cell 172:1122-1131.e1129CrossRefPubMed
16.
go back to reference 16 Gao W, Wang W, Song D et al (2022) A predictive model integrating deep and radiomics features based on gadobenate dimeglumine-enhanced MRI for postoperative early recurrence of hepatocellular carcinoma. Radiol Med 127:259-271CrossRefPubMed 16 Gao W, Wang W, Song D et al (2022) A predictive model integrating deep and radiomics features based on gadobenate dimeglumine-enhanced MRI for postoperative early recurrence of hepatocellular carcinoma. Radiol Med 127:259-271CrossRefPubMed
18.
go back to reference 18 Di Leo G, Sardanelli F (2016) Pitfalls of Systematic Reviews and Meta-Analyses. Radiology 279:652CrossRefPubMed 18 Di Leo G, Sardanelli F (2016) Pitfalls of Systematic Reviews and Meta-Analyses. Radiology 279:652CrossRefPubMed
19.
go back to reference 19 Arya S, Kaji AH, Boermeester MA (2021) PRISMA Reporting Guidelines for Meta-analyses and Systematic Reviews. JAMA Surg 156:789-790CrossRefPubMed 19 Arya S, Kaji AH, Boermeester MA (2021) PRISMA Reporting Guidelines for Meta-analyses and Systematic Reviews. JAMA Surg 156:789-790CrossRefPubMed
20.
go back to reference 20 Sadeghi R, Treglia G (2017) Systematic reviews and meta-analyses of diagnostic studies: a practical guideline. Clinical and Translational Imaging 5:83-87CrossRef 20 Sadeghi R, Treglia G (2017) Systematic reviews and meta-analyses of diagnostic studies: a practical guideline. Clinical and Translational Imaging 5:83-87CrossRef
21.
go back to reference 21 Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158:280-286CrossRefPubMed 21 Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158:280-286CrossRefPubMed
22.
go back to reference 22 Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749-762CrossRefPubMed 22 Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749-762CrossRefPubMed
23.
go back to reference 23 Qu Q, Lu M, Xu L et al (2023) A model incorporating histopathology and preoperative gadoxetic acid-enhanced MRI to predict early recurrence of hepatocellular carcinoma without microvascular invasion after curative hepatectomy. Br J Radiol 96:20220739CrossRefPubMedPubMedCentral 23 Qu Q, Lu M, Xu L et al (2023) A model incorporating histopathology and preoperative gadoxetic acid-enhanced MRI to predict early recurrence of hepatocellular carcinoma without microvascular invasion after curative hepatectomy. Br J Radiol 96:20220739CrossRefPubMedPubMedCentral
24.
go back to reference 24 Mo ZY, Chen PY, Lin J, Liao JY (2023) Pre-operative MRI features predict early post-operative recurrence of hepatocellular carcinoma with different degrees of pathological differentiation. Radiol Med 128:261-273CrossRefPubMedPubMedCentral 24 Mo ZY, Chen PY, Lin J, Liao JY (2023) Pre-operative MRI features predict early post-operative recurrence of hepatocellular carcinoma with different degrees of pathological differentiation. Radiol Med 128:261-273CrossRefPubMedPubMedCentral
25.
go back to reference 25 Zhang L, Chen J, Jiang H et al (2022) MR elastography as a biomarker for prediction of early and late recurrence in HBV-related hepatocellular carcinoma patients before hepatectomy. Eur J Radiol 152:110340CrossRefPubMedPubMedCentral 25 Zhang L, Chen J, Jiang H et al (2022) MR elastography as a biomarker for prediction of early and late recurrence in HBV-related hepatocellular carcinoma patients before hepatectomy. Eur J Radiol 152:110340CrossRefPubMedPubMedCentral
26.
go back to reference 26 Wang L, Ma X, Feng B et al (2022) Multi-Sequence MR-Based Radiomics Signature for Predicting Early Recurrence in Solitary Hepatocellular Carcinoma ≤5 cm. Front Oncol 12:899404CrossRefPubMedPubMedCentral 26 Wang L, Ma X, Feng B et al (2022) Multi-Sequence MR-Based Radiomics Signature for Predicting Early Recurrence in Solitary Hepatocellular Carcinoma ≤5 cm. Front Oncol 12:899404CrossRefPubMedPubMedCentral
27.
go back to reference 27 Wang L, Feng B, Wang S et al (2022) Diagnostic value of whole-tumor apparent diffusion coefficient map radiomics analysis in predicting early recurrence of solitary hepatocellular carcinoma ≤ 5 cm. Abdom Radiol (NY) 47:3290-3300CrossRefPubMed 27 Wang L, Feng B, Wang S et al (2022) Diagnostic value of whole-tumor apparent diffusion coefficient map radiomics analysis in predicting early recurrence of solitary hepatocellular carcinoma ≤ 5 cm. Abdom Radiol (NY) 47:3290-3300CrossRefPubMed
28.
go back to reference 28 Zhao Y, Wu J, Zhang Q et al (2021) Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy. J Magn Reson Imaging 53:1066-1079CrossRefPubMed 28 Zhao Y, Wu J, Zhang Q et al (2021) Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy. J Magn Reson Imaging 53:1066-1079CrossRefPubMed
29.
go back to reference 29 Lee S, Kim SH, Hwang JA, Lee JE, Ha SY (2019) Pre-operative ADC predicts early recurrence of HCC after curative resection. Eur Radiol 29:1003-1012CrossRefPubMed 29 Lee S, Kim SH, Hwang JA, Lee JE, Ha SY (2019) Pre-operative ADC predicts early recurrence of HCC after curative resection. Eur Radiol 29:1003-1012CrossRefPubMed
30.
go back to reference 30 Yang D, She H, Wang X, Yang Z, Wang Z (2020) Diagnostic accuracy of quantitative diffusion parameters in the pathological grading of hepatocellular carcinoma: A meta-analysis. J Magn Reson Imaging 51:1581-1593CrossRefPubMed 30 Yang D, She H, Wang X, Yang Z, Wang Z (2020) Diagnostic accuracy of quantitative diffusion parameters in the pathological grading of hepatocellular carcinoma: A meta-analysis. J Magn Reson Imaging 51:1581-1593CrossRefPubMed
31.
go back to reference 31 Qiu J, Peng B, Tang Y et al (2017) CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study. J Clin Oncol 35:734-742CrossRefPubMed 31 Qiu J, Peng B, Tang Y et al (2017) CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study. J Clin Oncol 35:734-742CrossRefPubMed
32.
go back to reference 32 Lei Z, Li J, Wu D et al (2016) Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria. JAMA Surg 151:356-363CrossRefPubMed 32 Lei Z, Li J, Wu D et al (2016) Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria. JAMA Surg 151:356-363CrossRefPubMed
33.
go back to reference 33 Tian H, Xie Y, Wang Z (2023) Radiomics for preoperative prediction of early recurrence in hepatocellular carcinoma: a meta-analysis. Front Oncol 13:1114983CrossRefPubMedPubMedCentral 33 Tian H, Xie Y, Wang Z (2023) Radiomics for preoperative prediction of early recurrence in hepatocellular carcinoma: a meta-analysis. Front Oncol 13:1114983CrossRefPubMedPubMedCentral
34.
go back to reference 34 Vauthey JN, Klimstra D, Franceschi D et al (1995) Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169:28-34; discussion 34-25CrossRefPubMed 34 Vauthey JN, Klimstra D, Franceschi D et al (1995) Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169:28-34; discussion 34-25CrossRefPubMed
35.
go back to reference 35 Lijmer JG, Bossuyt PM, Heisterkamp SH (2002) Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 21:1525-1537CrossRefPubMed 35 Lijmer JG, Bossuyt PM, Heisterkamp SH (2002) Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 21:1525-1537CrossRefPubMed
36.
go back to reference 36 Hwang S, Lee YJ, Kim KH et al (2015) The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients. J Gastrointest Surg 19:1281-1290CrossRefPubMed 36 Hwang S, Lee YJ, Kim KH et al (2015) The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients. J Gastrointest Surg 19:1281-1290CrossRefPubMed
37.
go back to reference 37 Hao S, Fan P, Chen S, Tu C, Wan C (2016) Anterior approach to improve the long-term outcome in patients with large-size hepatocellular carcinoma having liver resection. J Surg Oncol 114:872-878CrossRefPubMed 37 Hao S, Fan P, Chen S, Tu C, Wan C (2016) Anterior approach to improve the long-term outcome in patients with large-size hepatocellular carcinoma having liver resection. J Surg Oncol 114:872-878CrossRefPubMed
Metadata
Title
Preoperative prediction power of radiomics and non-radiomics methods based on MRI for early recurrence in hepatocellular carcinoma: a systemic review and meta-analysis
Authors
Mingjie Lu
Chen Wang
Yi Zhuo
Junjiu Gou
Yingfeng Li
Jingqi Li
Xue Dong
Publication date
05-05-2024
Publisher
Springer US
Published in
Abdominal Radiology
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-024-04356-y
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.